TY - JOUR
T1 - Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome
T2 - An Emerging and Challenging Prenatal Diagnosis
AU - Favier, Maud
AU - Brischoux-Boucher, Elise
AU - Pyle, Louise C.
AU - Mottet, Nicolas
AU - Auber-Lenoir, Marion
AU - Cattin, Julie
AU - Dahlen, Eric
AU - Cabrol, Christelle
AU - Arbez-Gindre, Francine
AU - Attie-Bitach, Tania
AU - Boute, Odile
AU - Devisme, Louise
AU - Trost, Detlef
AU - Boughalem, Aicha
AU - Chitayat, David
AU - Prasov, Lev
AU - Chorin, Odelia
AU - Rein-Rothschild, Annick
AU - Kassif, Eran
AU - Weissbach, Tal
AU - Hendon, Laura Godfrey
AU - Adam, Margaret P.
AU - Quelin, Chloe
AU - Jaillard, Sylvie
AU - Mary, Laura
AU - Aukema, Sietse M.
AU - Heijligers, Malou
AU - de Die-Smulders, Christine
AU - Stegmann, Sander
AU - Badalato, Lauren
AU - Ben-Yehuda, Adi
AU - Beneteau, Claire
AU - Forey, Pierre-Louis
AU - Kuentz, Paul
AU - Piard, Juliette
PY - 2024/12
Y1 - 2024/12
N2 - PurposeMYRF-related cardiac-urogenital syndrome (MYRF-CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF-CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF-CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant.MethodsDetailed radiographic, pathological, clinical, and molecular data from 12 prenatal cases were collected through an international collaborative study. Adding the five fetuses previously published, we were able to study a cohort of 17 cases.ResultsMain ultrasound-accessible manifestations of MYRF-CUGS include congenital heart defects (13/17, 76%), congenital diaphragmatic hernia (10/17, 59%) and disorders of sexual differentiation in 46, XY fetuses (7/14; 50%). Postnatal examination and/or autopsy data highlighted additional birth defects and neurological findings with a large spectrum of severity. Molecular results revealed ten previously unpublished variants, one missense and nine predicted truncating variants (three frameshift, three nonsense and three splice site variants).ConclusionWe report the first prenatal cohort of MYRF-CUGS, allowing us to further characterize the variable expressivity of this rare disorder in fetuses. Severe congenital anomalies with a poor prognosis are more frequent than previously described in postnatal cases. Our data suggest that MYRF-CUGS is characterized by a recurrent recognizable malformative association, accessible to prenatal diagnosis, with a significant intrafamilial phenotypic variability making genetic counseling challenging.
AB - PurposeMYRF-related cardiac-urogenital syndrome (MYRF-CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF-CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF-CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant.MethodsDetailed radiographic, pathological, clinical, and molecular data from 12 prenatal cases were collected through an international collaborative study. Adding the five fetuses previously published, we were able to study a cohort of 17 cases.ResultsMain ultrasound-accessible manifestations of MYRF-CUGS include congenital heart defects (13/17, 76%), congenital diaphragmatic hernia (10/17, 59%) and disorders of sexual differentiation in 46, XY fetuses (7/14; 50%). Postnatal examination and/or autopsy data highlighted additional birth defects and neurological findings with a large spectrum of severity. Molecular results revealed ten previously unpublished variants, one missense and nine predicted truncating variants (three frameshift, three nonsense and three splice site variants).ConclusionWe report the first prenatal cohort of MYRF-CUGS, allowing us to further characterize the variable expressivity of this rare disorder in fetuses. Severe congenital anomalies with a poor prognosis are more frequent than previously described in postnatal cases. Our data suggest that MYRF-CUGS is characterized by a recurrent recognizable malformative association, accessible to prenatal diagnosis, with a significant intrafamilial phenotypic variability making genetic counseling challenging.
KW - GENE REGULATORY FACTOR
KW - MYELIN
KW - NANOPHTHALMOS
KW - VARIANTS
U2 - 10.1002/pd.6700
DO - 10.1002/pd.6700
M3 - Article
SN - 0197-3851
VL - 44
SP - 1647
EP - 1658
JO - Prenatal Diagnosis
JF - Prenatal Diagnosis
IS - 13
ER -